RECRUITING

U01-Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is an observational, biospecimen collection protocol to develop a bank of pancreatic cancer tissue and normal tissue.

Official Title

U01-Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer

Quick Facts

Study Start:2018-09-15
Study Completion:2024-09-15
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03886571

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Not specified
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Males or Females ≥ 18 years of age who have been diagnosed with Pancreatic Cancer (PDAC), Pancreatic Neoplasms (PNs - IPMMs, PanINs and MCNs), pancreatitis and diabetes or no disease/healthy.
  2. * Individuals undergoing or have previously undergone a diagnostic procedure (i.e. EUS or ERCP) evaluation or surgery.
  3. * Willingness and ability to donate biospecimens for the purpose of research.
  4. * Subjects must have had diagnostic procedure or surgery after September 1, 2017.
  1. * Individuals under 18 years of age.
  2. * Inability to donate biospecimens.
  3. * Females pregnant or lactating.

Contacts and Locations

Study Contact

Leila Andres, MS
CONTACT
949-764-5543
Clinicalresearch@hoag.org

Study Locations (Sites)

Hoag Memorial Hospital Presbyterian
Newport Beach, California, 92663
United States

Collaborators and Investigators

Sponsor: Hoag Memorial Hospital Presbyterian

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2018-09-15
Study Completion Date2024-09-15

Study Record Updates

Study Start Date2018-09-15
Study Completion Date2024-09-15

Terms related to this study

Additional Relevant MeSH Terms

  • Pancreatic Cancer